rs10410805 - PEPD

Magnitude 2.2 · 1 study on file

Reported associations

  • Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes - Unknown journal (n.d.) · Unknown authors · PubMed 39379762

    ABSTRACT: Type 2 diabetes (T2D) genome-wide association studies (GWASs) often overlook rare variants as a result of previous imputation panels' limitations and scarce whole-genome sequencing (WGS) data. We used TOPMed imputation and WGS to conduct the largest T2D GWAS meta-analysis involving 51,256 cases of T2D and 370,487 controls, targeting variants with a minor allele frequency as low as 5 × 10−5. We identified 12 new variants, including a rare African/African American-enriched enhancer variant near the LEP gene (rs147287548), associated with fourfold increased T2D risk. We also identified a rare missense variant in HNF4A (p.Arg114Trp), associated with eightfold increased T2D risk, previously reported in maturity-onset diabetes of the young with reduced penetrance, but observed


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • personalized Type 2 diabetes risk and prevention High

    Genetic risk stratification enables targeted prevention in susceptible individuals.

    discuss screening intervals, dietary optimization, and exercise targets

Exercise

  • regular aerobic and resistance exercise Moderate

    Physical activity improves insulin sensitivity and beta-cell function.

    150 min/week moderate cardio plus resistance training 2-3 times weekly

Screening

  • fasting glucose and HbA1c High

    Early detection of dysglycemia enables timely intervention before disease progression.

    baseline screening by age 35-40, repeat every 3-5 years or per clinical judgment